Tranferrins receptor association and endosomal localization of soluble HFE are not sufficient for regulation of cellular iron homeostasis

Iron uptake and storage are tightly regulated to guarantee sufficient iron for essential cellular processes and to prevent the production of damaging free radicals. A non‐classical class I MHC molecule, the hemochromatosis factor HFE, has been shown to regulate iron metabolism, potentially via its direct interaction with the transferrin receptor (TfR). In this study, we demonstrate that a soluble β2microglobulin‐HFE monochain (sHFE) folds with β2microglobulin (β2m) and associates with the TfR, indicating that the transmembrane and cytoplasmic domains are not necessary for assembly and trafficking through the ER‐Golgi network. We also demonstrate human TfR‐specific uptake and accumulation of extracellular sHFE by treated cells. The sHFE localized to the endosomal compartment albeit we observed variation in the time taken for endosomal trafficking between different cell types. The sHFE monochain was effective in reducing Tf uptake into cells, however this did not correlate to any changes in TfR or ferritin synthesis, in contrast to the HFE‐induced increase and decrease of TfR and ferritin, respectively. These findings of incongruent sHFE activity suggest that either variation in affinity binding of sHFE to TfR prevents efficient modulation of iron‐regulated proteins or that HFE has multiple functions some of which may be independent of TfR but dependent on interactions within the endosomal compartment for effective modulation of iron metabolism. © 2004 Wiley‐Liss, Inc.

[1]  M. Lampson,et al.  Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. , 2003, The Biochemical journal.

[2]  J. Yewdell,et al.  A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. , 2003, Blood.

[3]  A. Townsend,et al.  The hemochromatosis protein HFE inhibits iron export from macrophages , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Leclerc.  Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions. , 2002, Critical care medicine.

[5]  W. Sly,et al.  Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Paige S. Davies,et al.  Increased IRP1 and IRP2 RNA binding activity accompanies a reduction of the labile iron pool in HFE‐expressing cells * , 2002, Journal of cellular physiology.

[7]  G. Forni,et al.  Death Receptor Ligands in Tumors , 2002, Journal of immunotherapy.

[8]  J. Yewdell,et al.  Human Cytomegalovirus Protein US2 Interferes with the Expression of Human HFE, a Nonclassical Class I Major Histocompatibility Complex Molecule That Regulates Iron Homeostasis , 2001, Journal of Virology.

[9]  J. Oppenheim,et al.  Cytokines: Past, Present, and Future , 2001, International journal of hematology.

[10]  M. Núñez,et al.  HFE inhibits apical iron uptake by intestinal epithelial (Caco‐2) cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  C. Chitambar,et al.  Iron transport in a lymphoid cell line with the hemochromatosis C282Y mutation. , 2001, Blood.

[12]  M. Worwood,et al.  The effects of wild-type and mutant HFE expression upon cellular iron uptake in transfected human embryonic kidney cells. , 2001, Biochimica et biophysica acta.

[13]  A. West,et al.  Binding to the transferrin receptor is required for endocytosis of HFE and regulation of iron homeostasis , 2000, Nature Cell Biology.

[14]  C. Gardner,et al.  The use of TNF family ligands and receptors and agents which modify their interaction as therapeutic agents. , 2000, Current drug targets.

[15]  J. Feder,et al.  Interactions of the ectodomain of HFE with the transferrin receptor are critical for iron homeostasis in cells , 2000, FEBS letters.

[16]  S. J. Smith,et al.  Localization of iron transport and regulatory proteins in human cells. , 2000, QJM : monthly journal of the Association of Physicians.

[17]  M. Colombo,et al.  Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. , 2000, Blood.

[18]  F. Kishi,et al.  Human NRAMP2/DMT1, Which Mediates Iron Transport across Endosomal Membranes, Is Localized to Late Endosomes and Lysosomes in HEp-2 Cells* , 2000, The Journal of Biological Chemistry.

[19]  A. J. Parodi,et al.  Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. , 2000, The Biochemical journal.

[20]  N. Andrews,et al.  Genes that modify the hemochromatosis phenotype in mice. , 2000, The Journal of clinical investigation.

[21]  Y. Kohgo,et al.  Overexpression of hemochromatosis protein, HFE, alters transferrin recycling process in human hepatoma cells. , 2000, Biochimica et biophysica acta.

[22]  P. Bjorkman,et al.  Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor , 2000, Nature.

[23]  M. Hentze,et al.  HFE downregulates iron uptake from transferrin and induces iron-regulatory protein activity in stably transfected cells. , 1999, Blood.

[24]  A. West,et al.  The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. , 1999, Journal of molecular biology.

[25]  A. Corti,et al.  Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces an iron‐deficient phenotype , 1999, FEBS letters.

[26]  M. Jackson,et al.  Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. M. Penny,et al.  The Hereditary Hemochromatosis Protein, HFE, Specifically Regulates Transferrin-mediated Iron Uptake in HeLa Cells* , 1999, The Journal of Biological Chemistry.

[28]  W. Sly,et al.  Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Mason,et al.  Kupffer cell staining by an HFE‐specific monoclonal antibody: implications for hereditary haemochromatosis , 1998, British journal of haematology.

[30]  J. Feder,et al.  Co-trafficking of HFE, a Nonclassical Major Histocompatibility Complex Class I Protein, with the Transferrin Receptor Implies a Role in Intracellular Iron Regulation* , 1998, The Journal of Biological Chemistry.

[31]  J. Coligan,et al.  MHC Class I Heavy Chain mRNA Must Exceed a Threshold Level for the Reconstitution of Cell Surface Expression of Class I MHC Complexes in Cells Transformed by the Highly Oncogenic Adenovirus 12* , 1998, The Journal of Biological Chemistry.

[32]  P. Bjorkman,et al.  Crystal Structure of the Hemochromatosis Protein HFE and Characterization of Its Interaction with Transferrin Receptor , 1998, Cell.

[33]  D. M. Penny,et al.  The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  W. Sly,et al.  Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Sly,et al.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Wolff,et al.  The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.

[37]  W. Sly,et al.  Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[39]  H. Lodish,et al.  Cab45, a novel (Ca2+)-binding protein localized to the Golgi lumen , 1996, The Journal of cell biology.

[40]  S. Ho,et al.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.

[41]  F. Lemonnier,et al.  Human beta 2-microglobulin specifically enhances cell-surface expression of HLA class I molecules in transfected murine cells. , 1988, Journal of immunology.

[42]  J. Weissman,et al.  The action of molecular chaperones in the early secretory pathway. , 2001, Annual review of genetics.

[43]  F. Montero-Julian.  The soluble IL-6 receptors: serum levels and biological function. , 2001, Cellular and molecular biology.

[44]  W. Sly,et al.  Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes. , 2000, Haematologica.